AXS-05 Phase II Trial on Smoking Behavior

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This research study is designed with the purpose of evaluating a new drug, combination Dextromethorphan-Bupropion (AXS-05), for its effects on smoking behavior.
Epistemonikos ID: 1daada90c9b4ceafd89c1944a938f8e39e727cd0
First added on: May 21, 2024